home

Brazilian Zika doctors find severe brain damage in babies: study

Frontierreuters2016-04-14 14:57 Read   72

Brazilian scientists studying possible links between birth defects and the mosquito-borne Zika virus have found that babies born with microcephaly have severe brain damage with a range of abnormalities.

Pharma primed to invest in services, but will patients get the message?

Frontierfiercepharma2016-04-14 13:17 Read   68

Patient services are no longer an add-on but a must-have. That's one of the conclusions in a new report from Accenture ($ACN)--one that also finds that pharma companies are putting their money in the game.

Greater odds for lower cognitive function in older patients with persistent AF

Frontierhealio2016-03-29 11:15 Read   119

In community-dwelling older adults, persistent atrial fibrillation is associated with lower cognitive function, according to new data from the ARIC study.

Sisense Plans Another US Office As It Scales Up in Big Data Analytics

Frontierxconomy2016-03-29 10:30 Read   134

There is a race on to develop analytics software that can turn the vast amounts of data generated these days into something useful for businesses—and it will likely get harder to keep up.

Dr. Reddy’s Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829

FrontierBusinesswire2016-03-29 10:10 Read   113

Dr. Reddy's Laboratories and XenoPort, announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral new chemical entity, XP23829.

Aduro Biotech helps launch new immunotherapy, vaccine effort

FrontierUC BERKELEY2016-03-29 09:58 Read   127

UC Berkeley cancer immunologists are teaming up with colleagues working on infectious disease to create a new Immunotherapeutics and Vaccine Research Initiative, fueled by $7.5 million in funding from Aduro Biotech, Inc., a Berkeley company that develops immunotherapies for cancer and other diseases.

Strong patent regime the only way to boost drug innovation

FrontierFirstword2016-03-28 10:20 Read   177

Sanjiv Navangul, managing director of Janssen India, said the company will not sell tuberculosis drug bedaquiline, which was recently launched in the country, in the private market, Business Line reported.

Scientists have identified the molecules most capable of fighting prostate cancer

Frontiersciencealert2016-03-25 09:48 Read   92

Better than chemotherapy.

AACR preview – Novel targets in the spotlight

FrontierEP Vantage2016-03-21 15:58 Read   197

The annual meeting of the American Association for Cancer Research has steadily been gaining in importance, and when its latest instalment kicks off in New Orleans next month investors will be watching particularly for initial data from novel cancer immunotherapy mechanisms.

The CRISPR patent fight pits Broad against Berkeley, with three biotechs in the middle

FrontierStat story2016-03-10 15:45 Read   317

The ongoing dispute over who owns the rights to a potentially revolutionary gene editing technology is finally headed to court, as the U.S. Patent and Trademark Office prepares to weigh in on a dispute with major implications for biotech.

Vitamin D, calcium do not reduce risk for colorectal adenomas

FrontierPharmacodia.com2015-10-15 00:00 Read   308

Daily supplementation with vitamin D, calcium or both did not significantly decrease risk for recurrent colorectal adenomas, according to the results of a randomized, double blind, placebo-controlled trial.